Impact of comorbidities on the disability progression in multiple sclerosis.

Gorica MaricTatjana PekmezovicOlivera TamasNikola VeselinovicAleksa JovanovicKatarina LalicSarlota MesarosJelena S Drulovic

Published in: Acta neurologica Scandinavica (2021)

Our study confirms the impact of CVD comorbidities and type 2 diabetes in MS on the progression of disability as measured by EDSS in the large cohort of PwMS from the population Registry.

Keyphrases

multiple sclerosis
type diabetes
white matter
mass spectrometry
insulin resistance
weight loss